Fourth Generation Phosphorus-Containing Dendrimers: Prospective Drug and Gene Delivery Carrier
Research concerning new targeting delivery systems for pharmacologically active molecules and genetic material is of great importance. The aim of the present study was to investigate the potential of fourth generation (P4) cationic phosphorus-containing dendrimers to bind fluorescent probe 8-anilino...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2011-08-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | http://www.mdpi.com/1999-4923/3/3/458/ |
| _version_ | 1798034858049536000 |
|---|---|
| author | V. Dzmitruk A. Shakhbazau D. Shcharbin A. Chernov V. Kulchitsky A.-M. Caminade J.-P. Majoral M. Talabaev M. Bryszewska E. Pedziwiatr-Werbicka M. Potapnev S. Kosmacheva I. Seviaryn N. Goncharova |
| author_facet | V. Dzmitruk A. Shakhbazau D. Shcharbin A. Chernov V. Kulchitsky A.-M. Caminade J.-P. Majoral M. Talabaev M. Bryszewska E. Pedziwiatr-Werbicka M. Potapnev S. Kosmacheva I. Seviaryn N. Goncharova |
| author_sort | V. Dzmitruk |
| collection | DOAJ |
| description | Research concerning new targeting delivery systems for pharmacologically active molecules and genetic material is of great importance. The aim of the present study was to investigate the potential of fourth generation (P4) cationic phosphorus-containing dendrimers to bind fluorescent probe 8-anilino-1-naphthalenesulfonate (ANS), anti-neoplastic drug cisplatin, anti-HIV siRNA siP24 and its capability to deliver green fluorescent protein gene (pGFP) into cells. The interaction between P4 and ANS (as the model drug) was investigated. The binding constant and the number of binding centers per one molecule of P4 were determined. In addition, the dendriplex between P4 and anti-HIV siRNA siP24 was characterized using circular dichroism, fluorescence polarization and zeta-potential methods; the average hydrodynamic diameter of the dendriplex was calculated using zeta-size measurements. The efficiency of transfection of pGFP using P4 was determined in HEK293 cells and human mesenchymal stem cells, and the cytotoxicity of the P4-pGFP dendriplex was studied. Furthermore, enhancement of the toxic action of the anti-neoplastic drug cisplatin by P4 dendrimers was estimated. Based on the results, the fourth generation cationic phosphorus-containing dendrimers seem to be a good drug and gene delivery carrier candidate. |
| first_indexed | 2024-04-11T20:50:14Z |
| format | Article |
| id | doaj.art-7a6edab5c48e4cbc96be15782b75e936 |
| institution | Directory Open Access Journal |
| issn | 1999-4923 |
| language | English |
| last_indexed | 2024-04-11T20:50:14Z |
| publishDate | 2011-08-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceutics |
| spelling | doaj.art-7a6edab5c48e4cbc96be15782b75e9362022-12-22T04:03:52ZengMDPI AGPharmaceutics1999-49232011-08-013345847310.3390/pharmaceutics3030458Fourth Generation Phosphorus-Containing Dendrimers: Prospective Drug and Gene Delivery CarrierV. DzmitrukA. ShakhbazauD. ShcharbinA. ChernovV. KulchitskyA.-M. CaminadeJ.-P. MajoralM. TalabaevM. BryszewskaE. Pedziwiatr-WerbickaM. PotapnevS. KosmachevaI. SeviarynN. GoncharovaResearch concerning new targeting delivery systems for pharmacologically active molecules and genetic material is of great importance. The aim of the present study was to investigate the potential of fourth generation (P4) cationic phosphorus-containing dendrimers to bind fluorescent probe 8-anilino-1-naphthalenesulfonate (ANS), anti-neoplastic drug cisplatin, anti-HIV siRNA siP24 and its capability to deliver green fluorescent protein gene (pGFP) into cells. The interaction between P4 and ANS (as the model drug) was investigated. The binding constant and the number of binding centers per one molecule of P4 were determined. In addition, the dendriplex between P4 and anti-HIV siRNA siP24 was characterized using circular dichroism, fluorescence polarization and zeta-potential methods; the average hydrodynamic diameter of the dendriplex was calculated using zeta-size measurements. The efficiency of transfection of pGFP using P4 was determined in HEK293 cells and human mesenchymal stem cells, and the cytotoxicity of the P4-pGFP dendriplex was studied. Furthermore, enhancement of the toxic action of the anti-neoplastic drug cisplatin by P4 dendrimers was estimated. Based on the results, the fourth generation cationic phosphorus-containing dendrimers seem to be a good drug and gene delivery carrier candidate.http://www.mdpi.com/1999-4923/3/3/458/phosphorus-containing dendrimerdrug deliverygene deliverydendriplex characterizationtransfectionmesenchymal stem cellstumorcisplatin |
| spellingShingle | V. Dzmitruk A. Shakhbazau D. Shcharbin A. Chernov V. Kulchitsky A.-M. Caminade J.-P. Majoral M. Talabaev M. Bryszewska E. Pedziwiatr-Werbicka M. Potapnev S. Kosmacheva I. Seviaryn N. Goncharova Fourth Generation Phosphorus-Containing Dendrimers: Prospective Drug and Gene Delivery Carrier Pharmaceutics phosphorus-containing dendrimer drug delivery gene delivery dendriplex characterization transfection mesenchymal stem cells tumor cisplatin |
| title | Fourth Generation Phosphorus-Containing Dendrimers: Prospective Drug and Gene Delivery Carrier |
| title_full | Fourth Generation Phosphorus-Containing Dendrimers: Prospective Drug and Gene Delivery Carrier |
| title_fullStr | Fourth Generation Phosphorus-Containing Dendrimers: Prospective Drug and Gene Delivery Carrier |
| title_full_unstemmed | Fourth Generation Phosphorus-Containing Dendrimers: Prospective Drug and Gene Delivery Carrier |
| title_short | Fourth Generation Phosphorus-Containing Dendrimers: Prospective Drug and Gene Delivery Carrier |
| title_sort | fourth generation phosphorus containing dendrimers prospective drug and gene delivery carrier |
| topic | phosphorus-containing dendrimer drug delivery gene delivery dendriplex characterization transfection mesenchymal stem cells tumor cisplatin |
| url | http://www.mdpi.com/1999-4923/3/3/458/ |
| work_keys_str_mv | AT vdzmitruk fourthgenerationphosphoruscontainingdendrimersprospectivedrugandgenedeliverycarrier AT ashakhbazau fourthgenerationphosphoruscontainingdendrimersprospectivedrugandgenedeliverycarrier AT dshcharbin fourthgenerationphosphoruscontainingdendrimersprospectivedrugandgenedeliverycarrier AT achernov fourthgenerationphosphoruscontainingdendrimersprospectivedrugandgenedeliverycarrier AT vkulchitsky fourthgenerationphosphoruscontainingdendrimersprospectivedrugandgenedeliverycarrier AT amcaminade fourthgenerationphosphoruscontainingdendrimersprospectivedrugandgenedeliverycarrier AT jpmajoral fourthgenerationphosphoruscontainingdendrimersprospectivedrugandgenedeliverycarrier AT mtalabaev fourthgenerationphosphoruscontainingdendrimersprospectivedrugandgenedeliverycarrier AT mbryszewska fourthgenerationphosphoruscontainingdendrimersprospectivedrugandgenedeliverycarrier AT epedziwiatrwerbicka fourthgenerationphosphoruscontainingdendrimersprospectivedrugandgenedeliverycarrier AT mpotapnev fourthgenerationphosphoruscontainingdendrimersprospectivedrugandgenedeliverycarrier AT skosmacheva fourthgenerationphosphoruscontainingdendrimersprospectivedrugandgenedeliverycarrier AT iseviaryn fourthgenerationphosphoruscontainingdendrimersprospectivedrugandgenedeliverycarrier AT ngoncharova fourthgenerationphosphoruscontainingdendrimersprospectivedrugandgenedeliverycarrier |